180 related articles for article (PubMed ID: 15592671)
1. Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML).
George B; Poonkuzhali B; Srivastava VM; Chandy M; Srivastava A
Ann Hematol; 2005 Jun; 84(6):406-8. PubMed ID: 15592671
[TBL] [Abstract][Full Text] [Related]
2. Molecular remission with arsenic trioxide in patients with newly diagnosed acute promyelocytic leukemia.
George B; Mathews L; Balasubramanian P; Shaji RV; Srivastava A; Chandy M
Haematologica; 2004 Oct; 89(10):1266-7. PubMed ID: 15477216
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R
Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
[TBL] [Abstract][Full Text] [Related]
4. Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.
Cassinat B; Guillemot I; Moluçon-Chabrot C; Zassadowski F; Fenaux P; Tournilhac O; Chomienne C
Haematologica; 2006 Dec; 91(12 Suppl):ECR58. PubMed ID: 17194664
[TBL] [Abstract][Full Text] [Related]
5. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
[TBL] [Abstract][Full Text] [Related]
6. Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience.
Lazo G; Kantarjian H; Estey E; Thomas D; O'Brien S; Cortes J
Cancer; 2003 May; 97(9):2218-24. PubMed ID: 12712474
[TBL] [Abstract][Full Text] [Related]
7. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F
Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
[TBL] [Abstract][Full Text] [Related]
8. [Monitoring of minimal residual disease in patients with acute promyelocytic leukemia].
Shuravina EN; Parovichnikova EN; Demidova IA; Misiurin AV; Isaev VG; Ol'shanskaia IuV; Savchenko VG
Ter Arkh; 2006; 78(7):25-31. PubMed ID: 16944747
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
[TBL] [Abstract][Full Text] [Related]
10. Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3).
Zhang T; Westervelt P; Hess JL
Mod Pathol; 2000 Sep; 13(9):954-61. PubMed ID: 11007035
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute promyelocytic leukemia: a single institution experience.
Ruiz-Argüelles GJ; Morales-Toquero A; Gómez-Rangel JD; López-Martínez B; Ruiz-Delgado GJ; Reyes-Núñez V
Rev Invest Clin; 2005; 57(3):415-9. PubMed ID: 16187701
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: a single center experience.
Mathews V; Balasubramanian P; Shaji RV; George B; Chandy M; Srivastava A
Am J Hematol; 2002 Aug; 70(4):292-9. PubMed ID: 12210810
[TBL] [Abstract][Full Text] [Related]
13. [Liposomal daunorubicin and interferon-alfa in combination with all-retinoic acid--a new regime for the treatment of acute promyelocytic leukemia].
Savchenko VG; Parovichnikova EN; Isaev VG; Shuravina EN; Demidova IA; Ol'shanskaia IuV
Ter Arkh; 2002; 74(7):11-8. PubMed ID: 12181827
[TBL] [Abstract][Full Text] [Related]
14. Cryptic insertion (15;17) in a case of acute promyelocytic leukemia detected by fluorescence in situ hybridization.
Gutiérrez NC; García JL; Chillón C; Muntión S; González M; Hernández JM
Haematologica; 1999 Jan; 84(1):88-90. PubMed ID: 10091399
[No Abstract] [Full Text] [Related]
15. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
16. Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine.
Lu Q; Chen Y; Li Z
Leuk Res; 2012 Jun; 36(6):e119-21. PubMed ID: 22386731
[No Abstract] [Full Text] [Related]
17. Early relapse after non myeloablative allogeneic stem cell transplantation in a patient with acute promyelocytic leukemia in complete molecular remission.
Tavernier E; Thomas X
Indian J Cancer; 2003; 40(4):140-3. PubMed ID: 14716110
[TBL] [Abstract][Full Text] [Related]
18. Treatment concepts of acute promyelocytic leukemia.
Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias].
Parovichnikova EN; Savchenko VG; Demidova IA; Isaev VG; Shuravina EN; Ustinova EN; Gribanova EO; Aleksanian MZh; Misiurin AV; Domracheva EV; Ol'shanskaia IuV; Khoroshko ND; Kravchenko SK; Konstantinova TS; Anchukova LV; Kaplanov K; Zagoskina TP; Volkova SA; Filatov LB; Rekhtman GB; Sokolova I; Mashuk VN; Miliutina GI; Lapin VA; Perekatova TN; Sviridova EI; Pristupa AS; Ziuzgin IS
Ter Arkh; 2004; 76(7):11-8. PubMed ID: 15379121
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.
Lo Coco F; Diverio D; Avvisati G; Mandelli F
Haematologica; 1999 Jun; 84 Suppl EHA-4():72-4. PubMed ID: 10907474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
